📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Corvus Pharmaceuticals

1.1 - Company Overview

Corvus Pharmaceuticals Logo

Corvus Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical solutions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Corvus Pharmaceuticals

Alaunos Therapeutics Logo

Alaunos Therapeutics

HQ: United States Website
  • Description: Provider of TCR-T cell therapies and supporting platforms for cancer treatment, including non-viral TCR-T therapy for solid tumors, the Sleeping Beauty transposition system for TCR gene transfer, the hunTR discovery engine to identify new TCRs, and a clinical TCR library targeting frequent mutations such as KRAS, TP53, and EGFR, backed by in-house manufacturing for rapid, cost-effective TCR-T production.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alaunos Therapeutics company profile →
Orega Biotech Logo

Orega Biotech

HQ: France Website
  • Description: Provider of immunotherapeutic monoclonal antibodies for cancer, including IPH5201, a humanized CD39 blocking antibody that inhibits adenosine production and is in Phase 2 trials for non-small cell lung cancer, and a novel preclinical human-mouse cross-reactive blocking antibody that improves the efficacy of anti-PD-1 therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orega Biotech company profile →
Kairos Therapeutics Logo

Kairos Therapeutics

HQ: Canada Website
  • Description: Provider of a proprietary next-generation antibody-drug conjugate platform as a biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kairos Therapeutics company profile →
GlobeImmune Logo

GlobeImmune

HQ: United States Website
  • Description: Provider of a proprietary Tarmogen® platform used to develop products for the treatment of cancer and infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GlobeImmune company profile →
Abcuro Logo

Abcuro

HQ: United States Website
  • Description: Provider of immunotherapies for autoimmunity and cancer, including ABC008, a monoclonal antibody targeting KLRG1 to selectively deplete highly cytotoxic T cells in inclusion body myositis, T-cell large granular lymphocytic leukemia, and certain cancers, and ABC015, a preclinical antibody blocking KLRG1-ligand interaction to activate cytotoxic T and NK cells; conducts clinical trials for ABC008 in IBM and T-LGLL.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abcuro company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Corvus Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Corvus Pharmaceuticals

2.2 - Growth funds investing in similar companies to Corvus Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Corvus Pharmaceuticals

4.2 - Public trading comparable groups for Corvus Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Corvus Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Corvus Pharmaceuticals

What does Corvus Pharmaceuticals do?

Corvus Pharmaceuticals is a provider of clinical-stage biopharmaceutical solutions.

Who are Corvus Pharmaceuticals's competitors?

Corvus Pharmaceuticals's competitors and similar companies include Alaunos Therapeutics, Orega Biotech, Kairos Therapeutics, GlobeImmune, and Abcuro.

Where is Corvus Pharmaceuticals headquartered?

Corvus Pharmaceuticals is headquartered in United States.

How many employees does Corvus Pharmaceuticals have?

Corvus Pharmaceuticals has 1,000 employees 🔒.

When was Corvus Pharmaceuticals founded?

Corvus Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Corvus Pharmaceuticals in?

Corvus Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Corvus Pharmaceuticals

Who are the top strategic acquirers in Corvus Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Corvus Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Corvus Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Corvus Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Corvus Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Corvus Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Corvus Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Corvus Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Corvus Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Corvus Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Corvus Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Corvus Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Corvus Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Corvus Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Corvus Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Corvus Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Corvus Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Corvus Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Corvus Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Corvus Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Corvus Pharmaceuticals